Skip to main content
Log in

The Simultaneous Estimation of the Influx and Efflux Blood-Brain Barrier Permeabilities of Gabapentin Using a Microdialysis-Pharmacokinetic Approach

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To determine the apparent bidirectional permeabilities of gabapentin (GBP) across the blood-brain barrier (BBB) using a novel microdialysis-pharmacokinetic approach.

Methods. Rats were administered intravenous infusions of [14C]GBP to achieve clinically relevant steady-state plasma concentrations. Microdialysis was used to monitor GBP concentration in brain extracellular fluid (ECF) in conscious animals. Brain tissue GBP concentration was measured at termination. The BBB influx (CL1) and efflux (CL2) permeabilities of GBP were estimated with a hybrid pharmacokinetic model assuming that transport between intra-and extracellular space was more rapid than transport across the BBB. The time course of GBP concentration in brain tissue was determined independently to validate the model assumption.

Results and Conclusions. Simulations of the concentration-time course of GBP in brain tissue based on this modeling correlated well with the time-course of brain tissue concentrations determined after intravenous bolus administration and validated this pharmacokinetic-microdialysis approach for estimation of BBB permeabilities. The values for CL1 and CL2 were 0.042 (0.017) and 0.36 (0.16) ml/min·g-brain, respectively, indicating that GBP was more efficiently transported from brain ECF to plasma. The total brain tissue concentration of GBP was significantly higher than the ECF concentration at steady-state due to intracellular accumulation and tissue binding, that if not considered, will lead to underestimated efflux BBB permeability using the tissue homogenate-pharmacokinetic approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. J. Kehr. A survey on quantitative microdialysis: theoretical models and practical implications. J. Neurosci. Methods 48:251–261 (1993).

    Google Scholar 

  2. Y. Wang, S. L. Wong, and R. J. Sawchuk. Microdialysis calibration using retrodialysis and zero-net flux: Application to a study of the distribution of zidovudine to rabbit CSF and thalamus. Pharm. Res. 10, 1411–1419 (1993).

    Google Scholar 

  3. Y. Wang and R. J. Sawchuk. Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion. J. Pharm. Sci. 84:871–876 (1995).

    Google Scholar 

  4. Y. Takasato, S. I. Rapoport, Q. R. Smith. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 16:H484–H493 (1984).

    Google Scholar 

  5. H. Benveniste and P. C. Huttemeier. Microdialysis: Theory and application. Progress in Neurobiology. 35:195–215 (1990).

    Google Scholar 

  6. D. F. Welty, G. P. Schielke, M. G. Vartanian, C. P. Taylor. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res. 16:175–181 (1993).

    Google Scholar 

  7. L. L. Radulovic, D. Turck, A. Von Hodenberg, K.-O. Vollmer, W. P. McNally, P. D. Dehart, B. J. Hanson, H. N. Bockbrader, and T. Chang. Disposition of gabapentin (Neurontin) in mice, rats, dogs, and monkeys. Drug Met. Disp. 23:441–448 (1995).

    Google Scholar 

  8. Rosenberg, G. A. Brain Fluids and Metabolism, Oxford University Press, New York, NY, 1990, pp. 15–53.

    Google Scholar 

  9. B. K. Malhotra, M. Lemaire, and R. J. Sawchuk. Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely moving rats utilizing microdialysis. Pharm. Res. 11:1223–1232 (1994).

    Google Scholar 

  10. C. I. Larsson. The use of an ‘internal standard’ for control of recovery in microdialysis. Life Sci. 49:73–78 (1991).

    Google Scholar 

  11. D. Scheller and J. Kolb. The internal reference technique in microdialysis: A practical approach to monitoring dialysis efficiency and calculating tissue concentration from dialysate samples. J. Neurosci. Methods 40:31–48 (1991).

    Google Scholar 

  12. E. Ben-Menachem, L. I. Persson and T. Hedner. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin. Epilepsy Res. 11:45–49 (1992).

    Google Scholar 

  13. M. Bradbury. The Concept of a Blood-Brain Barrier, John Wiley & Sons, New York, 1979, pp 120.

    Google Scholar 

  14. D. O. Cooney. Biomedical Engineering Principles, Marcel Dekker, Inc., New York, 1976.

    Google Scholar 

  15. K. H. Dykstra, A. Arya, D. M. Arriola, P. M. Bungay, P. F. Morrison, and R. L. Dedrick. Microdialysis study of zidovudine (AZT) transport in rat brain. J. Pharmacol. Exp. Therap. 267:1227–1236 (1993).

    Google Scholar 

  16. W. M. Pardridge. Brain drug delivery and blood-brain barrier transport. Drug Delivery. 1:83–101 (1993).

    Google Scholar 

  17. T.-Z. Su, E. Lunney, G. Campbell, and D. L. Oxender. Transport of gabapentin, a γ-amino acid drug, by system L α-amino acid transporters: a comparative study in astrocytes, synaptosomes and CHO cells. J. Neurochem. 64:2125–2131 (1995).

    Google Scholar 

  18. H. F. Cserr and C. S. Patlak. Secretion and bulk flow of interstitial fluid. In M. W. B. Bradbury (eds.), Physiology and Pharmacology of the Blood-Brain Barrier, Springer-Verlag, New York, NY, 1993, pp. 246–253.

    Google Scholar 

  19. M. B. Segal and B. V. Zlokovic. The Blood-Brain Barrier, Amino Acids and Peptides. Kluwer Academic Publishers, Boston, 1990, pp 37.

    Google Scholar 

  20. G. D. Bartoszyk, N. Meyerson, W. Reimann, G. Satzinger., A. Von Hodenberg. In: Current Problems in Epilepsy, vol. 4, Anticonvulsant Drugs, Eds. Meldrum B.S., Porter R. J., London, John Libbey 1986, 147–163.

    Google Scholar 

  21. B. H. Stewart, A. R. Kugler, P. R. Thompson, and H. N. Bockbrader. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm. Res. 10:276–281 (1993).

    Google Scholar 

  22. H. Davson, B. Zlokovic, L. Rakic, and M. B. Segal. An Introduction to the Blood-Brain Barrier. CRC Press, Inc., Ann Arbor, 1993, p. 174.

    Google Scholar 

  23. D. C. Markovitz and J. D. Fernstrom. Diet and uptake of aldomet by the brain: competition with natural large neutral amino acids. Science 197:1014–1015(1977).

    Google Scholar 

  24. A. L. Betz and G. W. Goldstein. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science, 202:225–226 (1978).

    Google Scholar 

  25. R. J. Thurlow, J. P. Brown, N. S. Gee, D. R. Hill, and G. N. Woodruff. [3H]gabapentin may label a system-L-like neutral amino acid carrier in brain. Eur. J. Pharmacol., Mol. Pharmacol. 247:341–345 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Welty, D.R. The Simultaneous Estimation of the Influx and Efflux Blood-Brain Barrier Permeabilities of Gabapentin Using a Microdialysis-Pharmacokinetic Approach. Pharm Res 13, 398–403 (1996). https://doi.org/10.1023/A:1016092525901

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016092525901

Navigation